Exelon Corp: Form 10-Q for the period ended Sep 30, 2022
Filed with the SEC on Nov 3, 2022 and accepted by EDGAR at Nov 3, 2022, 17:06 ET.
Sections
The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2022-09-30. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 3 months2022-07-01 to 2022-09-30 | $4.84bn | us-gaap:Revenues |
| Revenue | 9 months2022-01-01 to 2022-09-30 | $14.41bn | us-gaap:Revenues |
| Operating income | 3 months2022-07-01 to 2022-09-30 | $1.01bn | us-gaap:OperatingIncomeLoss |
| Operating income | 9 months2022-01-01 to 2022-09-30 | $2.61bn | us-gaap:OperatingIncomeLoss |
| Income tax | 3 months2022-07-01 to 2022-09-30 | $92.0m | us-gaap:IncomeTaxExpenseBenefit |
| Income tax | 9 months2022-01-01 to 2022-09-30 | $356.0m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months2022-07-01 to 2022-09-30 | $676.0m | us-gaap:ProfitLoss |
| Net income | 9 months2022-01-01 to 2022-09-30 | $1.74bn | us-gaap:ProfitLoss |
| Diluted shares (weighted) | 3 months2022-07-01 to 2022-09-30 | 989,000,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Diluted shares (weighted) | 9 months2022-01-01 to 2022-09-30 | 984,000,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 9 months2022-01-01 to 2022-09-30 | $4.14bn | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 9 months2022-01-01 to 2022-09-30 | $5.18bn | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Dividends paid | 9 months2022-01-01 to 2022-09-30 | $999.0m | us-gaap:PaymentsOfDividendsCommonStock |
| Cash and equivalents | At period end2022-09-30 | $446.0m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2022-09-30 | $7.05bn | us-gaap:AssetsCurrent |
| Total assets | At period end2022-09-30 | $93.45bn | us-gaap:Assets |
| Current liabilities | At period end2022-09-30 | $8.72bn | us-gaap:LiabilitiesCurrent |
| Total liabilities | At period end2022-09-30 | $68.87bn | us-gaap:Liabilities |
| Long-term debt | At period end2022-09-30 | $35.28bn | us-gaap:LongTermDebtNoncurrent |
| Short-term borrowings | At period end2022-09-30 | $1.69bn | us-gaap:ShortTermBorrowings |
| Shareholders' equity | At period end2022-09-30 | $24.58bn | us-gaap:StockholdersEquity |
| Shares outstanding | At period end2022-09-30 | 993,742,030 shares | dei:EntityCommonStockSharesOutstanding |
Source: SEC EDGAR, the filing index for accession 0001109357-22-000113. Last ingested by Listed: Oct 30, 2026, 12:46 ET. Listed shows no prices and gives no investment advice.